Canopy Growth Receivables

Canopy Growth (CGC) currently reports a receivables of $61M as of June 2026. That compares with $50M in the prior-year period — up 21.0% year over year. Use the charts on this page to explore Canopy Growth's receivables history and peer comparisons.

Canopy Growth's receivables increased from $50M to $61M — a 21.0% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Canopy Growth reported $61M in receivables as of June 2026. That compares with $50M in the prior-year period — up 21.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $61M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Canopy Growth, and consider following CGC for alerts when major investors trade the stock.

Canopy Growth is classified in the Healthcare sector. On receivables, it currently shows $61M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CGC with unrelated industries.